Caredx update regarding raymond james & associates' conference

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the company has determined not to participate in the raymond james & associates' 44th annual institutional investors conference scheduled for later today in light of scheduling conflicts.
CDNA Ratings Summary
CDNA Quant Ranking